Zoltan Arany
Cardiovascular Disease · Somerville, MANPI 1659414118
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Pfizer at 31.6% of the total. Reporting peaked in 2021 at $13,750 and has fallen 93.7% since, to $860 in 2025.
Across 17 payments — averaging $1593.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$9K
- Alnylam Pharmaceuticals Inc.$6K
- Abiomed$6K
- Novo Nordisk AS$5K
- Agios Pharmaceuticals, Inc.$2K
- Eli Lilly$49
Across 6 payments — averaging $152,008 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$541K
- Sanofi US Services Inc.$371K
What the payments were for
- Consulting fees$13,66050%
- Speaking & faculty fees$12,25045%
- Travel & lodging$7523%
- Food & beverage$4272%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $8,570 |
| Alnylam Pharmaceuticals Inc. | 1 | $6,300 |
| Abiomed | 9 | $5,671 |
| Novo Nordisk AS | 1 | $4,500 |
| Agios Pharmaceuticals, Inc. | 1 | $2,000 |
| Eli Lilly | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$5,581
How this compares
$27,090 in reported general payments places this provider in the 85th percentile of 750 cardiovascular disease providers in Massachusetts.
Other cardiovascular disease in Somerville
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- Kevin CroceChestnut Hill$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.